Australia's largest stock trading and investment forum Australia's #1 stock forum

GMV g medical innovations holdings limited

8.33%

27.5¢

Report removed., page-17

First 17 Last

Share
Profile

Follow
drifter13

2,650 Posts.

4

10/04/18

12:04

Post #: 32344261
Share

Originally posted by lakota6 ↑

I am , unfortunately , starting to think CR at this moment . I was like you , and believed that there would not be any need in the near future for a CR .
No way could GMV get a loan of any decent amount on MOUs and only projected revenue.
The matter of Yacov purchasing is a valid question and further muddies the water.
This is my opinion only , and am happy to admit , I am totally confused atm.

Expand

yacov is obviously loaded, instead of him buying on market maybe he could just fund a CR if needed himself..

GMV Price at posting: 33.5¢ Sentiment: None Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

SEN

Senetas experiences stronger cash flow as revenue rises, flags FY27 sales pipeline

D3E

D3 Energy detects gas in South African helium hunt well

NVA

Nova Minerals achieves key milestone on path to Alaskan antimony production

IMR

Imricor Med and Philips launch commercial iMR lab solution

HotCopper Highlights Week 35: X2M, AnteoTech and Brighstar dominate forum chatter

4DX

4DMedical posts FY26 revenue growth as commercial deployment ramps up

AS2

Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus

CVL

Civmec earnings: Profit climbs as $1.4b order book backs FY27 growth

MEM

Memphasys receives early Thai FDA Felix approval

TGN

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

This thread is closed.

You may not reply to this discussion at this time.

First 17 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Report removed., page-17

Top Stories

Senetas experiences stronger cash flow as revenue rises, flags FY27 sales pipeline

D3 Energy detects gas in South African helium hunt well

Nova Minerals achieves key milestone on path to Alaskan antimony production

Imricor Med and Philips launch commercial iMR lab solution

HotCopper Highlights Week 35: X2M, AnteoTech and Brighstar dominate forum chatter

4DMedical posts FY26 revenue growth as commercial deployment ramps up

Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus

Civmec earnings: Profit climbs as $1.4b order book backs FY27 growth

Memphasys receives early Thai FDA Felix approval

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

Featured News